BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Kamada Ltd. 

Kibbutz Beit Kama M.P.

Negev    85325  Israel
Phone: 07-991-2082 Fax: 07-991-2083


SEARCH JOBS


Industry
Biotechnology

Segment
Pharmaceuticals





 Company News
Kamada Ltd. (KMDA.TA) Announces U.S. Proof-Of-Concept Study With Glassia® For Graft-Versus-Host Disease 4/3/2014 9:23:56 AM    More...
Kamada Ltd. (KMDA.TA) Announces Initiation Of A Phase 2 U.S. Clinical Trial Of Inhaled AAT To Treat Alpha-1 Antitrypsin Deficiency 3/24/2014 7:49:04 AM    More...
Kamada Ltd. (KMDA.TA) To Report Top-Line Data From Phase 2/3 Clinical Trial Of Inhaled AAT To Treat Alpha-1 Antitrypsin Deficiency By Late April Or Early May 3/21/2014 8:55:34 AM    More...
Kamada Ltd. (KMDA.TA) Initiates Phase 2/3 Clinical Trial Of Glassia To Treat Newly Diagnosed Pediatric Patients With Type 1 Diabetes 3/5/2014 9:18:29 AM    More...
Kamada Ltd. (KMDA.TA) Completes Enrollment In U.S. Pivotal Clinical Trial With Kamrab As A Post-Exposure Treatment For Rabies 3/4/2014 10:06:44 AM    More...
Kamada Ltd. (KMDA.TA) To Ring The NASDAQ Stock Market Opening Bell On February 25, 2014 2/24/2014 9:25:38 AM    More...
Kamada Ltd. (KMDA.TA) Reports 2013 Fourth Quarter And Full Year Financial Results 2/5/2014 7:28:45 AM    More...
Kamada Ltd. (KMDA.TA) To Host Fourth Quarter And Full Year 2013 Financial Results Conference Call On Wednesday, February 5, 2014 1/31/2014 8:17:03 AM    More...
Kamada Ltd. (KMDA.TA) Announces Completion Of Pivotal Phase 2/3 Clinical Trial In Europe And Canada Of Inhaled AAT To Treat Alpha-1 Antitrypsin Deficiency 12/11/2013 8:49:43 AM    More...
Kamada Ltd. (KMDA.TA) Announces Appointment Of Amir London As Senior Vice President, Business Development 12/9/2013 8:01:49 AM    More...
12345678

//-->